Transaction totals about $3 billion
The EQT X fund (EQT Private Equity), and Mubadala Investment Company have agreed to acquire Envirotainer—a provider of secure cold-chain solutions for the air transportation of pharmaceuticals—for approximately $3 billion. The deal is expected to close Q3 of this year.
The parties will seek to support Envirotainer in its next phase of growth by accelerating expansion in Asia-Pacific (APAC) and continuing growth in its other markets. They plan to help scale the newly launched CryoSure offering, while continuing the roll-out of the third-generation Releye platform.
“The temperature-controlled distribution of pharma products offers very attractive and thematic exposure to the fast-growing biopharma end-market,” says Ali Farahani, partner within EQT Private Equity’s advisory team. “Envirotainer is an integral part of the global pharmaceutical infrastructure … We continue to see significant growth potential ahead and are excited to partner with the management team to unlock the full potential together with our partners at Mubadala.”
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.